- Home
- MEI vs AQST Comparison
MEI vs AQST Comparison
Compare MEI & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEI
- AQST
- Stock Information
- Founded
- MEI 1946
- AQST 2004
- Country
- MEI United States
- AQST United States
- Employees
- MEI N/A
- AQST N/A
- Industry
- MEI Electrical Products
- AQST Biotechnology: Pharmaceutical Preparations
- Sector
- MEI Technology
- AQST Health Care
- Exchange
- MEI Nasdaq
- AQST Nasdaq
- Market Cap
- MEI 324.4M
- AQST 272.9M
- IPO Year
- MEI N/A
- AQST 2018
- Fundamental
- Price
- MEI $9.48
- AQST $3.31
- Analyst Decision
- MEI Buy
- AQST Strong Buy
- Analyst Count
- MEI 2
- AQST 6
- Target Price
- MEI $10.50
- AQST $10.67
- AVG Volume (30 Days)
- MEI 288.2K
- AQST 1.6M
- Earning Date
- MEI 07-10-2025
- AQST 08-05-2025
- Dividend Yield
- MEI 5.91%
- AQST N/A
- EPS Growth
- MEI N/A
- AQST N/A
- EPS
- MEI N/A
- AQST N/A
- Revenue
- MEI $1,068,300,000.00
- AQST $54,228,000.00
- Revenue This Year
- MEI N/A
- AQST N/A
- Revenue Next Year
- MEI $1.16
- AQST $45.71
- P/E Ratio
- MEI N/A
- AQST N/A
- Revenue Growth
- MEI N/A
- AQST 5.29
- 52 Week Low
- MEI $5.08
- AQST $2.12
- 52 Week High
- MEI $17.45
- AQST $5.80
- Technical
- Relative Strength Index (RSI)
- MEI 67.51
- AQST 54.11
- Support Level
- MEI $8.57
- AQST $3.13
- Resistance Level
- MEI $9.31
- AQST $3.46
- Average True Range (ATR)
- MEI 0.31
- AQST 0.24
- MACD
- MEI -0.01
- AQST -0.04
- Stochastic Oscillator
- MEI 81.25
- AQST 17.52
About MEI Methode Electronics Inc.
Methode Electronics Inc makes component and subsystem devices employing electrical, radio remote control, electronic, wireless, and sensing technologies. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles. The products manufactured in the automotive segment include overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors. Geographically, the company generates maximum revenue from North America and the rest from Europe, the Middle East & Africa (EMEA), and Asia.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.